Indian Journal of Clinical and Experimental Ophthalmology

Print ISSN: 2395-1443

Online ISSN: 2395-1451

CODEN : IJCEKF

Indian Journal of Clinical and Experimental Ophthalmology (IJCEO) is open access, a peer-reviewed medical journal, published quarterly, online, and in print, by the Innovative Education and Scientific Research Foundation (IESRF) since 2015. To fulfil our aim of rapid dissemination of knowledge, we publish articles ‘Ahead of Print’ on acceptance. In addition, the journal allows free access (Open Access) to its content, which is likely to attract more readers and citations of articles published in IJCEO. Manuscripts must be prepared in more...

Article type

Original Article


Article page

468-473


Authors Details

Zakia Sultana*, Syeed Mehbub Ul Kadir, Syed A Hassan, Ashraf Sayeed, Ishrat Jahan, Ahmad Masud Rifat, Md Mahfuzur Rahman, Shahidul Islam, Abdul Khaleque Talukder, Rajendra Prakash Maurya


Article Metrics


View Article As

 


Downlaod Files

   






Article statistics

Viewed: 469

PDF Downloaded: 266


Visual improvement after corneal collagen cross-linking in keratoconus


Original Article

Author Details : Zakia Sultana*, Syeed Mehbub Ul Kadir, Syed A Hassan, Ashraf Sayeed, Ishrat Jahan, Ahmad Masud Rifat, Md Mahfuzur Rahman, Shahidul Islam, Abdul Khaleque Talukder, Rajendra Prakash Maurya

Volume : 8, Issue : 4, Year : 2022

Article Page : 468-473

https://doi.org/10.18231/j.ijceo.2022.095



Suggest article by email

Get Permission

Abstract

Purpose: This study was carried out to evaluate the effect of corneal collagen cross-linking on visual acuity, astigmatism and topographic readings (K1, K2, Kapex).
Materials and Methods: A nonrandomized noncontrolled clinical study was conducted in two tertiary eye centres in Bangladesh from July 2017 to June 2019. All attending patients diagnosed with Keratoconus were included in this study according to selection criteria. Patients with a corneal thickness of fewer than 400 microns, previous viral infection, cornea scarring, corneal opacification, severe ocular surface disease, history of immune disorders, pregnancy, and breastfeeding were excluded from the study. All selected patients underwent collagen cross-linking with Riboflavin and Ultraviolet A, followed up five days, one and six months following the procedure. Visual acuity, topographic readings (K1, K2, Kapex) and cylindrical values were assessed on every visit. The mean value of visual acuity was compared statistically with the baseline value.
Results: A total of 30 eyes of 30 patients were studied in this study. The male-to-female ratio was 2:1. The Mean age (± SD) of the study subjects was 22.7±7.10. Before CXL, the Mean uncorrected visual acuity (UCVA) ±SD was 0.86±.35. In post-CXL follow-up time, the mean UCVA±SD was 0.46±.23 after six months of CXL. Before CXL, the Mean BCVA±SD was 0.35±.22. In post CXL era, the Mean ± SD BCVA was 0.14±.13 after six months of CXL. The Mean K1±SD was 45.66±3.43 before CXL, and the result changed after CXL. The Mean K1±SD was 43.29±3.29 after six months of CXL. The Mean K2±SD was 50.22±5.93 before CXL, and the result differed after six months of CXL. The Mean Kapex ±SD was 54.50±7.38 before CXL, and that was 51.32±6.93 after six months of CXL.
Conclusion: Keratoconus is a bilateral non-inflammatory disorder progressively leading to vision-threatening ocular morbidity. Collagen cross-linking improves visual and topographic findings– K1, K2, and Kapex and reduces astigmatism. Early diagnosis of Keratoconus and prompt treatment will help achieve better vision.
 

Keywords: Corneal collagen cross- linking (CXL), Visual acuity, Topographic readings (K1, K2, Kapex).


How to cite : Sultana Z, Kadir S M U, Hassan S A, Sayeed A, Jahan I, Rifat A M, Rahman M M, Islam S, Talukder A K, Maurya R P, Visual improvement after corneal collagen cross-linking in keratoconus. Indian J Clin Exp Ophthalmol 2022;8(4):468-473

This is an Open Access (OA) journal, and articles are distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 License, which allows others to remix, tweak, and build upon the work non-commercially, as long as appropriate credit is given and the new creations are licensed under the identical terms.